Where’s my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol

[Display omitted] 2-Arachidonoylglycerol (2-AG) is the most abundant endogenous cannabinoid in the brain and an agonist at two cannabinoid receptors (CB1 and CB2). The synthesis, degradation and signaling of 2-AG have been investigated in detail but its relationship to other endogenous monoacylglyce...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacological research 2016-08, Vol.110, p.173-180
Hauptverfasser: Murataeva, Natalia, Dhopeshwarkar, Amey, Yin, Danielle, Mitjavila, José, Bradshaw, Heather, Straiker, Alex, Mackie, Ken
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 180
container_issue
container_start_page 173
container_title Pharmacological research
container_volume 110
creator Murataeva, Natalia
Dhopeshwarkar, Amey
Yin, Danielle
Mitjavila, José
Bradshaw, Heather
Straiker, Alex
Mackie, Ken
description [Display omitted] 2-Arachidonoylglycerol (2-AG) is the most abundant endogenous cannabinoid in the brain and an agonist at two cannabinoid receptors (CB1 and CB2). The synthesis, degradation and signaling of 2-AG have been investigated in detail but its relationship to other endogenous monoacylglycerols has not been fully explored. Three congeners that have been isolated from the CNS are 2-linoleoylglycerol (2-LG), 2-oleoylglycerol (2-OG), and 2-palmitoylglycerol (2-PG). These lipids do not orthosterically bind to cannabinoid receptors but are reported to potentiate the activity of 2-AG, possibly through inhibition of 2-AG degradation. This phenomenon has been dubbed the ‘entourage effect’ and has been proposed to regulate synaptic activity of 2-AG. To clarify the activity of these congeners of 2-AG we tested them in neuronal and cell-based signaling assays. The signaling profile for these compounds is inconsistent with an entourage effect. None of the compounds inhibited neurotransmission via CB1 in autaptic neurons. Interestingly, each failed to potentiate 2-AG-mediated depolarization-induced suppression of excitation (DSE), behaving instead as antagonists. Examining other signaling pathways we found that 2-OG interferes with agonist-induced CB1 internalization while 2-PG modestly internalizes CB1 receptors. However in tests of pERK, cAMP and arrestin recruitment, none of the acylglycerols altered CB1 signaling. Our results suggest 1) that these compounds do not serve as entourage compounds under the conditions examined, and 2) that they may instead serve as functional antagonists. Our results suggest that the relationship between 2-AG and its congeners is more nuanced than previously appreciated.
doi_str_mv 10.1016/j.phrs.2016.04.015
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5108301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043661816303346</els_id><sourcerecordid>1798721288</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-2da649cdd0c30090029a83355f10831fd5ace32c9860230f9eea13c9050cc5463</originalsourceid><addsrcrecordid>eNp9UU1r3DAQFaGlSZP-gRyCjz3U7oxkyzaEhhL6BYFeEnoUqjze1Ua2tpId2Fv_Rv9ef0llNgnJpScN7715M5rH2ClCgYDy_abYrkMseKoLKAvA6oAdIbQyR2zki6UuRS4lNofsdYwbAGhLhFfskNeItZT1Ebv9saZAf3__idmwy2ic_Bz0ii6y6zVlZg7WzzEzOlLm-4zn3pHfuZXbGQrevUuIs2MCx2eoHrvEbLUb7PSEOGEve-0ivbl_j9nN50_Xl1_zq-9fvl1-vMpNxXHKeadl2ZquAyPSxgC81Y0QVdUjNAL7rtKGBDdtI4EL6FsijcK0UIExVSnFMfuw993OPwfqTPpV0E5tgx102CmvrXrOjHatVv5OVcsAwGTw9t4g-F8zxUkNNhpyTo-U7qGwbpuaI2-aJOV7qQk-xkD94xgEtaSkNmpJSS0pKShVSik1nT1d8LHlIZYkON8LKJ3pzlJQ0VgaDXU2kJlU5-3__P8BhjumWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1798721288</pqid></control><display><type>article</type><title>Where’s my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Murataeva, Natalia ; Dhopeshwarkar, Amey ; Yin, Danielle ; Mitjavila, José ; Bradshaw, Heather ; Straiker, Alex ; Mackie, Ken</creator><creatorcontrib>Murataeva, Natalia ; Dhopeshwarkar, Amey ; Yin, Danielle ; Mitjavila, José ; Bradshaw, Heather ; Straiker, Alex ; Mackie, Ken</creatorcontrib><description>[Display omitted] 2-Arachidonoylglycerol (2-AG) is the most abundant endogenous cannabinoid in the brain and an agonist at two cannabinoid receptors (CB1 and CB2). The synthesis, degradation and signaling of 2-AG have been investigated in detail but its relationship to other endogenous monoacylglycerols has not been fully explored. Three congeners that have been isolated from the CNS are 2-linoleoylglycerol (2-LG), 2-oleoylglycerol (2-OG), and 2-palmitoylglycerol (2-PG). These lipids do not orthosterically bind to cannabinoid receptors but are reported to potentiate the activity of 2-AG, possibly through inhibition of 2-AG degradation. This phenomenon has been dubbed the ‘entourage effect’ and has been proposed to regulate synaptic activity of 2-AG. To clarify the activity of these congeners of 2-AG we tested them in neuronal and cell-based signaling assays. The signaling profile for these compounds is inconsistent with an entourage effect. None of the compounds inhibited neurotransmission via CB1 in autaptic neurons. Interestingly, each failed to potentiate 2-AG-mediated depolarization-induced suppression of excitation (DSE), behaving instead as antagonists. Examining other signaling pathways we found that 2-OG interferes with agonist-induced CB1 internalization while 2-PG modestly internalizes CB1 receptors. However in tests of pERK, cAMP and arrestin recruitment, none of the acylglycerols altered CB1 signaling. Our results suggest 1) that these compounds do not serve as entourage compounds under the conditions examined, and 2) that they may instead serve as functional antagonists. Our results suggest that the relationship between 2-AG and its congeners is more nuanced than previously appreciated.</description><identifier>ISSN: 1043-6618</identifier><identifier>EISSN: 1096-1186</identifier><identifier>DOI: 10.1016/j.phrs.2016.04.015</identifier><identifier>PMID: 27117667</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>2-AG ; 2-Arachidonoylglycerol ; 2-LG ; 2-Linolenoylglycerol ; 2-OG ; 2-Oleoylglycerol ; 2-Palmitoyglycerol ; 2-PG ; Acylglycerol ; Animals ; Arrestin - metabolism ; Cannabinoid ; Cannabinoid Receptor Antagonists - metabolism ; Cannabinoid Receptor Antagonists - pharmacology ; CB1 ; Cell Line ; Congener ; Cyclic AMP - metabolism ; Dose-Response Relationship, Drug ; Endocannabinoids - metabolism ; Endocannabinoids - pharmacology ; Entourage ; Extracellular Signal-Regulated MAP Kinases - metabolism ; Glycerides - metabolism ; Glycerides - pharmacology ; Hippocampus - cytology ; Hippocampus - drug effects ; Hippocampus - metabolism ; Humans ; Mice ; Neurons - drug effects ; Neurons - metabolism ; Phosphorylation ; Receptor, Cannabinoid, CB1 - antagonists &amp; inhibitors ; Receptor, Cannabinoid, CB1 - genetics ; Receptor, Cannabinoid, CB1 - metabolism ; Synaptic Transmission - drug effects ; Time Factors ; Transfection</subject><ispartof>Pharmacological research, 2016-08, Vol.110, p.173-180</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-2da649cdd0c30090029a83355f10831fd5ace32c9860230f9eea13c9050cc5463</citedby><cites>FETCH-LOGICAL-c521t-2da649cdd0c30090029a83355f10831fd5ace32c9860230f9eea13c9050cc5463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1043661816303346$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27117667$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murataeva, Natalia</creatorcontrib><creatorcontrib>Dhopeshwarkar, Amey</creatorcontrib><creatorcontrib>Yin, Danielle</creatorcontrib><creatorcontrib>Mitjavila, José</creatorcontrib><creatorcontrib>Bradshaw, Heather</creatorcontrib><creatorcontrib>Straiker, Alex</creatorcontrib><creatorcontrib>Mackie, Ken</creatorcontrib><title>Where’s my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol</title><title>Pharmacological research</title><addtitle>Pharmacol Res</addtitle><description>[Display omitted] 2-Arachidonoylglycerol (2-AG) is the most abundant endogenous cannabinoid in the brain and an agonist at two cannabinoid receptors (CB1 and CB2). The synthesis, degradation and signaling of 2-AG have been investigated in detail but its relationship to other endogenous monoacylglycerols has not been fully explored. Three congeners that have been isolated from the CNS are 2-linoleoylglycerol (2-LG), 2-oleoylglycerol (2-OG), and 2-palmitoylglycerol (2-PG). These lipids do not orthosterically bind to cannabinoid receptors but are reported to potentiate the activity of 2-AG, possibly through inhibition of 2-AG degradation. This phenomenon has been dubbed the ‘entourage effect’ and has been proposed to regulate synaptic activity of 2-AG. To clarify the activity of these congeners of 2-AG we tested them in neuronal and cell-based signaling assays. The signaling profile for these compounds is inconsistent with an entourage effect. None of the compounds inhibited neurotransmission via CB1 in autaptic neurons. Interestingly, each failed to potentiate 2-AG-mediated depolarization-induced suppression of excitation (DSE), behaving instead as antagonists. Examining other signaling pathways we found that 2-OG interferes with agonist-induced CB1 internalization while 2-PG modestly internalizes CB1 receptors. However in tests of pERK, cAMP and arrestin recruitment, none of the acylglycerols altered CB1 signaling. Our results suggest 1) that these compounds do not serve as entourage compounds under the conditions examined, and 2) that they may instead serve as functional antagonists. Our results suggest that the relationship between 2-AG and its congeners is more nuanced than previously appreciated.</description><subject>2-AG</subject><subject>2-Arachidonoylglycerol</subject><subject>2-LG</subject><subject>2-Linolenoylglycerol</subject><subject>2-OG</subject><subject>2-Oleoylglycerol</subject><subject>2-Palmitoyglycerol</subject><subject>2-PG</subject><subject>Acylglycerol</subject><subject>Animals</subject><subject>Arrestin - metabolism</subject><subject>Cannabinoid</subject><subject>Cannabinoid Receptor Antagonists - metabolism</subject><subject>Cannabinoid Receptor Antagonists - pharmacology</subject><subject>CB1</subject><subject>Cell Line</subject><subject>Congener</subject><subject>Cyclic AMP - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Endocannabinoids - metabolism</subject><subject>Endocannabinoids - pharmacology</subject><subject>Entourage</subject><subject>Extracellular Signal-Regulated MAP Kinases - metabolism</subject><subject>Glycerides - metabolism</subject><subject>Glycerides - pharmacology</subject><subject>Hippocampus - cytology</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Humans</subject><subject>Mice</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Phosphorylation</subject><subject>Receptor, Cannabinoid, CB1 - antagonists &amp; inhibitors</subject><subject>Receptor, Cannabinoid, CB1 - genetics</subject><subject>Receptor, Cannabinoid, CB1 - metabolism</subject><subject>Synaptic Transmission - drug effects</subject><subject>Time Factors</subject><subject>Transfection</subject><issn>1043-6618</issn><issn>1096-1186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU1r3DAQFaGlSZP-gRyCjz3U7oxkyzaEhhL6BYFeEnoUqjze1Ua2tpId2Fv_Rv9ef0llNgnJpScN7715M5rH2ClCgYDy_abYrkMseKoLKAvA6oAdIbQyR2zki6UuRS4lNofsdYwbAGhLhFfskNeItZT1Ebv9saZAf3__idmwy2ic_Bz0ii6y6zVlZg7WzzEzOlLm-4zn3pHfuZXbGQrevUuIs2MCx2eoHrvEbLUb7PSEOGEve-0ivbl_j9nN50_Xl1_zq-9fvl1-vMpNxXHKeadl2ZquAyPSxgC81Y0QVdUjNAL7rtKGBDdtI4EL6FsijcK0UIExVSnFMfuw993OPwfqTPpV0E5tgx102CmvrXrOjHatVv5OVcsAwGTw9t4g-F8zxUkNNhpyTo-U7qGwbpuaI2-aJOV7qQk-xkD94xgEtaSkNmpJSS0pKShVSik1nT1d8LHlIZYkON8LKJ3pzlJQ0VgaDXU2kJlU5-3__P8BhjumWA</recordid><startdate>20160801</startdate><enddate>20160801</enddate><creator>Murataeva, Natalia</creator><creator>Dhopeshwarkar, Amey</creator><creator>Yin, Danielle</creator><creator>Mitjavila, José</creator><creator>Bradshaw, Heather</creator><creator>Straiker, Alex</creator><creator>Mackie, Ken</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160801</creationdate><title>Where’s my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol</title><author>Murataeva, Natalia ; Dhopeshwarkar, Amey ; Yin, Danielle ; Mitjavila, José ; Bradshaw, Heather ; Straiker, Alex ; Mackie, Ken</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-2da649cdd0c30090029a83355f10831fd5ace32c9860230f9eea13c9050cc5463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>2-AG</topic><topic>2-Arachidonoylglycerol</topic><topic>2-LG</topic><topic>2-Linolenoylglycerol</topic><topic>2-OG</topic><topic>2-Oleoylglycerol</topic><topic>2-Palmitoyglycerol</topic><topic>2-PG</topic><topic>Acylglycerol</topic><topic>Animals</topic><topic>Arrestin - metabolism</topic><topic>Cannabinoid</topic><topic>Cannabinoid Receptor Antagonists - metabolism</topic><topic>Cannabinoid Receptor Antagonists - pharmacology</topic><topic>CB1</topic><topic>Cell Line</topic><topic>Congener</topic><topic>Cyclic AMP - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Endocannabinoids - metabolism</topic><topic>Endocannabinoids - pharmacology</topic><topic>Entourage</topic><topic>Extracellular Signal-Regulated MAP Kinases - metabolism</topic><topic>Glycerides - metabolism</topic><topic>Glycerides - pharmacology</topic><topic>Hippocampus - cytology</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Humans</topic><topic>Mice</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Phosphorylation</topic><topic>Receptor, Cannabinoid, CB1 - antagonists &amp; inhibitors</topic><topic>Receptor, Cannabinoid, CB1 - genetics</topic><topic>Receptor, Cannabinoid, CB1 - metabolism</topic><topic>Synaptic Transmission - drug effects</topic><topic>Time Factors</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murataeva, Natalia</creatorcontrib><creatorcontrib>Dhopeshwarkar, Amey</creatorcontrib><creatorcontrib>Yin, Danielle</creatorcontrib><creatorcontrib>Mitjavila, José</creatorcontrib><creatorcontrib>Bradshaw, Heather</creatorcontrib><creatorcontrib>Straiker, Alex</creatorcontrib><creatorcontrib>Mackie, Ken</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pharmacological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murataeva, Natalia</au><au>Dhopeshwarkar, Amey</au><au>Yin, Danielle</au><au>Mitjavila, José</au><au>Bradshaw, Heather</au><au>Straiker, Alex</au><au>Mackie, Ken</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Where’s my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol</atitle><jtitle>Pharmacological research</jtitle><addtitle>Pharmacol Res</addtitle><date>2016-08-01</date><risdate>2016</risdate><volume>110</volume><spage>173</spage><epage>180</epage><pages>173-180</pages><issn>1043-6618</issn><eissn>1096-1186</eissn><abstract>[Display omitted] 2-Arachidonoylglycerol (2-AG) is the most abundant endogenous cannabinoid in the brain and an agonist at two cannabinoid receptors (CB1 and CB2). The synthesis, degradation and signaling of 2-AG have been investigated in detail but its relationship to other endogenous monoacylglycerols has not been fully explored. Three congeners that have been isolated from the CNS are 2-linoleoylglycerol (2-LG), 2-oleoylglycerol (2-OG), and 2-palmitoylglycerol (2-PG). These lipids do not orthosterically bind to cannabinoid receptors but are reported to potentiate the activity of 2-AG, possibly through inhibition of 2-AG degradation. This phenomenon has been dubbed the ‘entourage effect’ and has been proposed to regulate synaptic activity of 2-AG. To clarify the activity of these congeners of 2-AG we tested them in neuronal and cell-based signaling assays. The signaling profile for these compounds is inconsistent with an entourage effect. None of the compounds inhibited neurotransmission via CB1 in autaptic neurons. Interestingly, each failed to potentiate 2-AG-mediated depolarization-induced suppression of excitation (DSE), behaving instead as antagonists. Examining other signaling pathways we found that 2-OG interferes with agonist-induced CB1 internalization while 2-PG modestly internalizes CB1 receptors. However in tests of pERK, cAMP and arrestin recruitment, none of the acylglycerols altered CB1 signaling. Our results suggest 1) that these compounds do not serve as entourage compounds under the conditions examined, and 2) that they may instead serve as functional antagonists. Our results suggest that the relationship between 2-AG and its congeners is more nuanced than previously appreciated.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>27117667</pmid><doi>10.1016/j.phrs.2016.04.015</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1043-6618
ispartof Pharmacological research, 2016-08, Vol.110, p.173-180
issn 1043-6618
1096-1186
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5108301
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects 2-AG
2-Arachidonoylglycerol
2-LG
2-Linolenoylglycerol
2-OG
2-Oleoylglycerol
2-Palmitoyglycerol
2-PG
Acylglycerol
Animals
Arrestin - metabolism
Cannabinoid
Cannabinoid Receptor Antagonists - metabolism
Cannabinoid Receptor Antagonists - pharmacology
CB1
Cell Line
Congener
Cyclic AMP - metabolism
Dose-Response Relationship, Drug
Endocannabinoids - metabolism
Endocannabinoids - pharmacology
Entourage
Extracellular Signal-Regulated MAP Kinases - metabolism
Glycerides - metabolism
Glycerides - pharmacology
Hippocampus - cytology
Hippocampus - drug effects
Hippocampus - metabolism
Humans
Mice
Neurons - drug effects
Neurons - metabolism
Phosphorylation
Receptor, Cannabinoid, CB1 - antagonists & inhibitors
Receptor, Cannabinoid, CB1 - genetics
Receptor, Cannabinoid, CB1 - metabolism
Synaptic Transmission - drug effects
Time Factors
Transfection
title Where’s my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T17%3A11%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Where%E2%80%99s%20my%20entourage?%20The%20curious%20case%20of%202-oleoylglycerol,%202-linolenoylglycerol,%20and%202-palmitoylglycerol&rft.jtitle=Pharmacological%20research&rft.au=Murataeva,%20Natalia&rft.date=2016-08-01&rft.volume=110&rft.spage=173&rft.epage=180&rft.pages=173-180&rft.issn=1043-6618&rft.eissn=1096-1186&rft_id=info:doi/10.1016/j.phrs.2016.04.015&rft_dat=%3Cproquest_pubme%3E1798721288%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1798721288&rft_id=info:pmid/27117667&rft_els_id=S1043661816303346&rfr_iscdi=true